Blood Coagulation.

Slides:



Advertisements
Similar presentations
Hemostasis Shaina Eckhouse 10/12/2010.
Advertisements

Chapter 12 Disorders of Hemostasis
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Coagulation failure in pregnancy
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
Bleeding and coagulation disorders
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
MLAB 1227: Coagulation Keri Brophy-Martinez
Disseminated intravascular coagulation (DIC)
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
An Introduction to Haemophilia and related bleeding disorders M QARI, MD, FRCPA.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
MISHA MAZHAR 2k10-NUST-BS-V&I-54.  Mutations in F8 or F9 genes.  Leads to lack of proteins made by these genes.  F8 responsible for making the blood.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Hemostasis and Blood Coagulation
Bleeding Disorders Dr. Farjah H.AlGahtani
Sarah Moreno Ms.Brown Child dev. -6
Approach to Bleeding Disorders
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
D ISODERS OF SECONDARY HEMOSTASIS Disorders of plasma clotting factors.
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
The hemophilias A and B X-linked hereditary blood clotting disorders due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) Identical.
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
February 4 th, The Child With Pain Single Joint Involvement Multiple Joint Involvement With Fever Septic arthritis/Osteomyelitis Sympathetic arthritis.
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Inherited bleeding disorder of primary hemostasis.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Congenital bleeding disorders
Approach To Bleeding Disorders In Neonates
Chapter 18 Disorders of Hemostasis
These factors prevent blood clotting - in normal state.
Coagulation cascade:.
Acquired coagulation disorders
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Congenital bleeding disorders
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
The Fascinating World of Haemostasis and Thrombosis
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
The child with hematological dysfunction
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Blood Coagulation

Haemostasis part2

ROLE OF ENDOTHILIUM

Stable Hemostatic Plug Hemostasis: BV Injury Tissue Factor Neural Coagulation Activation Blood Vessel Constriction Platelet Activation Primary hemostatic plug Reduced Blood flow Plt-Fusion Thromibn, Fibrin Stable Hemostatic Plug

Prothrombin Thrombin Coagulation: Intrinsic 12,11,9,8 (aPTT-) Extrinsic-7 (PT) Common Path (TT) FX  FXa Prothrombin Thrombin Fibrinogen  Fibrin

Clot formation & retraction Fibrinogen Thrombin F-XIIIa Fibrin Mononer Fibrin Polymer Cross Linked Fibrin

clot Procoagulant Profibrinolytic Anticoagulant Antifibrinolytic Platelets Factors Fibrinogen von Willebrand Factor Profibrinolytic Plasminogen tPA Fibrin Fragment D-dimer FORMATION RESOLUTION clot Anticoagulant Antithrombin III Protein C Protein S Antifibrinolytic PAI-1 Alpha-2 Antiplasmin

Role of thrombin

Fibrinolysis

Coagulation Made Easy- The Mixing Study Useful to differentiate etiologies of prolonged clotting in a coagulation assay. Patient’s plasma is mixed 50:50 with normal plasma. Coagulation assay is repeated. If “substantial” correction is noted after mix, suspect clotting factor deficiency. If no or minimal correction seen, suspect inhibitor.

Disorders of the haemostatic mechanism are devided into three main groups: Disorders of the vessels Disorders of the platelets Disorders of the coagulation mechanism („coagulopathies”) „ purpuric diseases”

The investigation of a patient with a suspected disorder of haemostasis case history (personal details, family history) inspection (type of bleeding) physical examination other known diseases drugs and medications laboratory tests

The main symptom of all diseases is the bleeding: Certain signs and symptoms are virtually diagnostic of disordered haemostasis. The main symptom of all diseases is the bleeding: ● in the „purpuric disorders” cutaneous and mucosal bleeding usually is prominent ● in different types of „coagulopathies” hemarthroses, haematomas are the characteristic bleeding manifestations. The onset of bleeding following trauma frequently is delayed (recur in a matter of hours) (the temporary hemostatic adequacy of the platelet plug may explain this phenomenon).

Petechiae, purpuras: small capillary haemorrhages ranging from the size of a pinhead to much larger

Petechiae, purpuras

Haematomas: may be spontaneous (in a serious hemorrhagic disease) or may occur after trauma (in a mild hemorrhagic disease).

Haematomas

Intramuscular injection may be very dangerous to the patient with a bleeding disorder Venipuncture (if skilfully performed) is without danger becouse the elasticity of the venous walls.

Bleeding Disorders

Coagulopathies Aquired: generally several coagulation abnormalities are present. Clinical picture is complicated by signs and symptoms of the underlying disease.  Deficiencies of the vitamin K dependent coagulation factors (FII, VII, IX, X)  Hepatic disorders  Accelerated destruction of blood coagulation (DIC)  Inhibitors of coagulation  Others (massive transfusion, extracorporal circulation) Hereditary: deficiency or abnormality of a single coagulation factor. Hemofilia A (FVIII) Hemofilia B (FIX) Von Willebrand’s disease Rare coagulopathies (FI. II. V. VII. X. XI. XIII)

Hereditary Factor Deficiencies Hemophilia x-linked recessive conditions (males only) type A : F VIII:C deficiency (Classical Hemophilia) B : F IX deficiency (Christmas disease) C : F XI deficiency unexplained bruising or bleeding in young males, usually ~ 1 yr of age joint & muscle bleeding → arthropathy

Haemophilia A bleeding disorder in which clotting factor VIII (eight) /Haemophilia A/ or IX (nine) /Haemophilia B/ in a person's blood plasma is missing or is at a low level. Prevalence: haemophilia A: 105/million men haemophilia B: 28/million men

In haemophilia, VIII or IX clotting factor is missing, or the level of that factor is low. This makes it difficult for the blood to form a clot, so bleeding continues longer than usual.

The hemophilia gene is carried on the X chromosome  in males who lack a normal allele, the defect is manifested by clinical haemophilia. Women may be carriers.

Haemophilia is a lifelong disease A person born with haemophilia will have it for life. The level of factor VIII or IX in his blood usually stays the same throughout his life.

hemophilia A

Hereditary Factor Deficiencies Hemophilia ■ screening: prolonged PTT ■ hemophilia A mild moderate severe : life-threatening (CNS bleed) treatment factor replacement rFVIIa

Factor VIII Concentrate Necessary for Hemostasis (% of normal) Spontaneous hemorrhage 1-3 % Moderate trauma 4-8 % Hemarthrosis/deep skeletal muscle hemorrhage 10-15 % Major surgery > 30%

Hemophilia B (Christmas disease, Factor IX def.) less common than hemophilia A similar clinical Sx and inheritance pattern as hemophilia A (sex-linked) XII XI IX VIII VII X V II I XIII Stable clot

von Willebrand’s disease easy bruisability (no bleeding into joints) unable to release VIII-vWF intact VIII-vWF synthesis VIII-C level is also decreased (unknown reason) autosomal dominant 1 in 30,000 population usually diagnosed in childhood or young adults increased bleeding time normal plt, PT normal or increased aPTT

Hereditary Platelet Disorder von Willebrand Disease (vWD) most common congenital bleeding disorder quantitative or qualitative abn. of vWF Type 1: most common form partial quantitative deficiency of vWF autosomal dominant mucocutaneous bleeding hematology consult prior to surgery prolonged bleeding time, normal platelet

Hereditary Platelet Disorders von Willebrand Disease (vWD) Type 2: qualitative alterations in the vWF structure & function Type 3: least common and most severe Complete absence of vWF in plasma or storage organelle Autosomal recessive acquired vWD Lymphoproliferative disease ▪ cardiac/valvular disease Tumors ▪ medications (valproic acid) Autoimmune disease ▪ hypothyroidism

Hereditary Platelet Disorders von Willebrand Disease Treatment: Desmopressin (DDAVP) synthetic analog of vasopressin ↑ both F VIII and vWF 3 - 5x in 30 mins preop prophylactic dose: 0.3 mcg/kg IV in 50 -100 ml NS infused 30-60 mins q 12-24 hrs PRN duration 8-10 hrs intranasal dose: 300 mcg – for home treatment, not for preop prophylaxis

Hereditary Bleeding Disorders von Willebrand Disease DDAVP vasomotor effect: flushing, ↑HR, headache SE: hyponatremia, seizures not for children < 3 yrs old unresponsive to DDAVP (15%) cryoprecipitate FFP factor VIII / vWF concentrate

Vitamin K Deficiency vitamin K dependent factors : II, VII, IX, X acquired disorder may occur in malnutrition, malabsorption, biliary obstruction, drug increased PT normal bleeding time, plt normal or increased aPTT XII XI IX VIII VII X V PT II I XIII Stable clot

Severe Liver Disease factors synthesized in liver : II, V, VII, IX, X, fibrinogen XII increased PT, aPTT normal bleeding time, plt XI IX VIII VII X V aPTT PT II I XIII Stable clot

Platelet Dysfunction, Factor Deficiencies & Presence of Inhibitors Liver disease • synthesis of coagulation factors (except VIII), anticoagulants, ATIII, protein C & S, plasminogen • clearance of activated clotting factors, tPA, FDPs DIC

Blood Component Therapy Transfusion of FFP 1) replacement of isolated factor deficiency 2) reversal of coumadin 3) antitrombin III deficiency 4) treatment of immunodeficiencies 5) treatment of TTP 6) massive blood transfusion

Blood Component Therapy Cryoprecipitate contains significant levels of factor VIIIC, factor VIII: vwF, XIII, fibrinogen indications: 1) hemophilia 2) von Willebrand disease 3) fibrinogen deficiencies 4) uremic platelet dysfunction

Coagulopathies

Disseminated Intravascular Coagulation (DIC) - an acute, subacute, or chronic thrombohemorrhagic disorder occurring as a secondary complication in a variety of diseases - activation of clotting system resulting in wide spread formation of microthrombi throughout the microcirculation - as a consequence, causing consumption of platelets, fibrin and coagulation factors, and activation of thrombolytic mechanism Two major triggering mechanisms 1. release of tissue factor or thromboplastic substance 2. widespread endothelial injury

DIC Triggering Mechanisms 1. release of tissue factor or thromboplastic substance - placental tissue - granules from leukemic cells - bacterial endotoxin - mucus from adeno CA 2. widespread endothelial injury - Ag-Ab immune complex deposit - extreme temperature - microorganisms

DIC Pathology: - wide spread thrombi (brain, heart, lungs, kidneys, adrenals, spleen , liver) - microinfarcts Clinical: - ~50% associated with obstetric complications - ~30% with carcinomatosis - microangiopathic anemia - dyspnea, cyanosis - convulsions, coma - oliguria, acute renal failure - shock, circulatory failure

DIC Clinical: acute DIC with a predominance of thrombin generation and consumption of coagulation factors bleeding tendency (oozing from venopuncutres or operating site) subacute and chronic DIC thrombotic tendency